X
Pfizer could fetch $15bn for consumer health business
https://pharmaphorum.com/news/pfizer-sell-consumer-healthcare-business/
M&A
Gilead completes $11.9bn Kite acquisition
October 4, 2017Gilead’s focus shifts from hepatitis C to CAR-T
Teva sells women’s health division to tackle $35bn debts
September 19, 2017
AZ tried to buy Daiichi Sankyo last year – report
August 31, 2017Trading in shares of Daiichi Sankyo was suspended yesterday.
Bidders lining up for Teva women’s health unit
August 24, 2017Allergan generics buyout left Teva with $35m debts
Trump tax reform uncertainty puts biotech M&A on hold
August 21, 2017Tesaro and Puma are potential takeover targets
BMS snaps up cancer biotech IFM in $2.3bn deal
August 4, 2017BMS will gain rights to preclinical cancer immunotherapy drugs.
Sanofi $750m acquisition gives it edge in flu vacccine market
July 11, 2017Biotech’s Flublok is only FDA-approved cell-based flu jab
CEO Meek looks to boost Ipsen with drug acquisitions
May 11, 2017Could French biotech snap up remaining rights to pancreatic cancer drug?
